Patents

US 11384156 B2: Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treating IgE-mediated allergic diseases

Granted
2022-07-12
Filed
2017-07-17 application 15651264
Type
Utility · 26 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A chimeric antigen receptor specific for the extracellular membrane-proximal domain (EMPD) of membrane-bound IgE (mIgE) is provided. The EMPD-specific chimeric antigen receptor comprises an extracellular ligand binding domain capable of binding EMPD, a transmembrane domain, and an intracellular domain that mediates T cell activation upon EMPD binding. Nucleic acids and vectors encoding the EMPD-specific chimeric antigen receptor are provided. T cells transduced with such vectors find use in chimeric antigen receptor-based adoptive T-cell therapy for targeting IgE-expressing B cells and treating IgE-mediated allergic diseases.

Source: PVGPATDIS, file of 2026-04-10 (ipg220712.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Nemours Foundation 18 patentsUS company or organizationJacksonville, FLTHE NEMOURS FOUNDATION State business registration EXACT high confidence: identical full name and state
THE NEMOURS FOUNDATION Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Zhengyu MaWard, PA3PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/4291PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P37/08PVGPATDIS, file of 2026-04-10
G02FOptical devices or arrangements for the control of light by modification of the optical properties of the media of the elements involved therein; non-linear optics; frequency-changing of light; optical logic elements; optical analogue/digital convertersG02F1/09PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K2039/505PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/11PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-02-06Assignment
Assignment of assignor's interest
MA, ZHENGYU signed 2017-12-06THE NEMOURS FOUNDATION JACKSONVILLE, FL44844/238ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.